1 Followers USX:BTX - Brooklyn ImmunoTherapeutics Inc Brooklyn ImmunoTherapeutics In
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance
Balance Sheet Cash Flow Income Statement Key Ratios
Adjust Display Metrics

Graphs are exclusive for members only

Sign up for free to access most features of StocksCafe

Show %
2020 Q1 2020 Q2 2021 Q1 2021 Q2 Graph
Total Assets - - 20.7M
-
64.71M
212.6%
Total Liabilities - - 25.12M
-
29.53M
17.5%
Total Equity - - -4.42M
-
35.18M
-
Operating CashFlow -1.87M
-
-2.18M
-
-3.43M
-
-6.8M
-
Investing CashFlow -4.46K
-
-21.72K
-
266.32K
-
-466
-
Financing CashFlow 312.5K
-
3.86M
1134.0%
9.94M
157.8%
48.56M
388.4%
Beginning Cash Position 5.1M
-
3.54M
-30.7%
1.63M
-53.9%
8.41M
415.8%
End Cash Position 3.54M
-
5.19M
46.7%
8.41M
62.1%
50.16M
496.5%
Free CashFlow -1.88M
-
-2.21M
-
-3.43M
-
-6.8M
-
Total Revenue 0
-
0
-
0
-
0
-
Net Income (Cont Operations) -1.02M
-
-2.03M
-
-17.7M
-
-10.09M
-
Diluted Net Income -1.02M
-
-2.03M
-
-17.7M
-
-10.09M
-
Diluted EPS -0.025
-
-0.049
-
-0.64
-
-0.24
-
Net Margin - - - -
Return On Equity - - - -65.62%
-
Return On Assets - - -85.53%
-
-23.64%
-
Values are in USD whenever applicable | Fiscal year ends on December 31
Powered by Morningstar